degradable starch microspheres

03/01/2007 - "Repeated transcatheter arterial chemoembolization with degradable starch microspheres decreased the tumors in size and improved the subjective symptoms. "
11/01/1986 - "We evaluated the efficacy of degradable starch microspheres (DSMs) to further increase drug delivery to hepatic tumors. "
03/01/1989 - "In animal studies hepatic arterial infusion of chemotherapeutic agents with degradable starch microspheres (DSMs) produces a redistribution of blood flow between tumor and liver and an increase in tumor drug levels. "
07/01/1988 - "This study used quantitative perfusion fluorometry (QPF) to evaluate blood flow distribution in liver and tumor before and after hepatic arterial infusion of degradable starch microspheres (DSMs) in 10 New Zealand white rabbits. "
01/01/1985 - "The use of degradable starch microspheres offers a new approach to the regional treatment of cancer and warrants further study."

06/01/2012 - "We used degradable starch microspheres (DSM) as finer obstructing material for the next treatment, and hepatic metastases were treated effectively with repeated CDDP/DSM-TACE."
10/01/1989 - "Temporary chemoembolization of colorectal liver metastases with degradable starch microspheres."
10/01/1987 - "Temporary blood flow stasis with degradable starch microspheres (DSM) for liver metastases in a rat model."
01/01/1985 - "Redistribution of arterial blood flow in metastases-bearing livers after infusion of degradable starch microspheres."
08/01/1992 - "Regional chemotherapy, either alone, or combined with agents such as degradable starch microspheres (DSM) that reduce or abolish intrahepatic arterial flow and potentiate the delivery of cytotoxics to hepatic metastases, have not significantly improved survival. "

10/01/2001 - "This study was undertaken to evaluate the clinical utility of chemoembolization using degradable starch microspheres (DSM), which resolve in a short period in patients with advanced hepatocellular carcinoma (HCC). "
06/28/2015 - "Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization."
06/15/2006 - "Adenovirus vector-mediated gene transfer using degradable starch microspheres for hepatocellular carcinoma in rats."
04/01/2003 - "Pilot study of transcatheter arterial chemoembolization with degradable starch microspheres in patients with hepatocellular carcinoma."
10/01/2001 - "[Transarterial chemoembolization (TAE) with degradable starch microspheres (DSM) in advanced hepatocellular carcinoma]."

12/20/1988 - "Part 3. Clinical studies on the effectiveness of hyperthermia combined with arterial chemo-embolization using degradable starch microspheres (DSM)]."
12/20/1988 - "Part 2. Experimental studies on the effectiveness of hyperthermia combined with arterial embolization using degradable starch microspheres (DSM)]."
02/01/1987 - "Hyperthermia with and without blood flow blockade of the hepatic artery using degradable starch microspheres was performed on six pigs. "
02/01/1987 - "The benefit of hepatic arterial microembolization by degradable starch microspheres (DSM) was investigated in regional hyperthermia of the liver. "
02/01/1987 - "Regional hyperthermia combined with blockade of the hepatic arterial blood flow by degradable starch microspheres in pigs."

10/01/2003 - "Recently, for the treatment of unresectable colorectal cancer with liver metastasis, hepatic artery injection of anticancer drugs suspended in degradable starch microspheres (DSM) is being performed. "
09/01/1994 - "Treatment of patients with irresectable liver metastases from colorectal cancer by chemo-occlusion with degradable starch microspheres."
04/01/1991 - "Transcatheter chemoembolization using degradable starch microspheres (DSM) was performed in 17 patients with liver metastases of colorectal cancer. "
04/01/1991 - "[Chemoembolization with degradable starch microspheres for liver metastases of colorectal cancer]."
08/01/1989 - "Transcatheter chemoembolization using Degradable Starch Microspheres (DSM) was performed in 17 patients with liver metastases of colorectal cancer. "